Applied Therapeutics (APLT) EPS (Weighted Average and Diluted) (2023 - 2025)
Historic EPS (Weighted Average and Diluted) for Applied Therapeutics (APLT) over the last 3 years, with Q3 2025 value amounting to -$0.13.
- Applied Therapeutics' EPS (Weighted Average and Diluted) rose 7291.67% to -$0.13 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.1, marking a year-over-year increase of 9378.88%. This contributed to the annual value of -$0.72 for FY2024, which is 4914.44% up from last year.
- Per Applied Therapeutics' latest filing, its EPS (Weighted Average and Diluted) stood at -$0.13 for Q3 2025, which was up 7291.67% from -$0.15 recorded in Q2 2025.
- In the past 5 years, Applied Therapeutics' EPS (Weighted Average and Diluted) ranged from a high of -$0.13 in Q2 2024 and a low of -$0.67 during Q1 2024
- For the 3-year period, Applied Therapeutics' EPS (Weighted Average and Diluted) averaged around -$0.3, with its median value being -$0.23 (2024).
- Per our database at Business Quant, Applied Therapeutics' EPS (Weighted Average and Diluted) crashed by 27222.22% in 2024 and then soared by 7761.19% in 2025.
- Over the past 3 years, Applied Therapeutics' EPS (Weighted Average and Diluted) (Quarter) stood at -$0.33 in 2023, then soared by 30.37% to -$0.23 in 2024, then surged by 43.42% to -$0.13 in 2025.
- Its EPS (Weighted Average and Diluted) was -$0.13 in Q3 2025, compared to -$0.15 in Q2 2025 and -$0.15 in Q1 2025.